{
    "key": "2017-0002",
    "name": "Hep B- Dose #4 administered at 24 weeks of age and at least 16 weeks from dose #1.",
    "cdcTestId": "2017-0002",
    "changedInVersion": "3.3",
    "dateAdded": "2016-01-30T00:00:00",
    "dateUpdated": "2020-06-18T08:10:17.702",
    "evaluation": {
        "administeredDoses": [
            {
                "cvx": "110",
                "dateAdministered": "2020-03-01T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "SKB",
                "vaccineName": "PEDIARIX"
            },
            {
                "cvx": "110",
                "dateAdministered": "2020-05-01T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "SKB",
                "vaccineName": "PEDIARIX"
            },
            {
                "cvx": "110",
                "dateAdministered": "2020-06-19T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "SKB",
                "vaccineName": "PEDIARIX"
            },
            {
                "cvx": "110",
                "dateAdministered": "2020-08-14T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "SKB",
                "vaccineName": "PEDIARIX"
            }
        ],
        "seriesStatus": "Complete"
    },
    "evaluationTestType": "All Valid: Forecast Test",
    "forecast": {
        "earliestDate": "0001-01-01T00:00:00",
        "forecastNum": "-",
        "pastDueDate": "0001-01-01T00:00:00",
        "recommendedDate": "0001-01-01T00:00:00"
    },
    "forecastTestType": "Not recommended: series complete",
    "generalDescription": "This test case describes when dose #4 of the HepB vaccine is administered  at least 24 weeks of age and at least 16 weeks from dose  #1,  that the dose is considered to be valid. Patient series is complete.",
    "patient": {
        "dob": "2019-11-30T00:00:00",
        "gender": "F",
        "medHistoryCode": "",
        "medHistoryCodeSys": "",
        "medHistoryText": "",
        "doses": [
            {
                "cvx": "110",
                "dateAdministered": "2020-03-01T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "SKB",
                "vaccineName": "PEDIARIX"
            },
            {
                "cvx": "110",
                "dateAdministered": "2020-05-01T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "SKB",
                "vaccineName": "PEDIARIX"
            },
            {
                "cvx": "110",
                "dateAdministered": "2020-06-19T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "SKB",
                "vaccineName": "PEDIARIX"
            },
            {
                "cvx": "110",
                "dateAdministered": "2020-08-14T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "SKB",
                "vaccineName": "PEDIARIX"
            }
        ]
    },
    "reasonForChange": "Updated dose #3 to valid since the interval is now at 0 days in the third dose of the HepB 4 dose series and the fourth dose was administered at least 16 weeks from dose #1..",
    "testcaseName": "Hep B- Dose #4 administered at 24 weeks of age and at least 16 weeks from dose #1.",
    "vaccineGroup": "HepB"
}